Montelukast Sodium NDC 31722-726

Product information

Brand name (proprietary)

Montelukast Sodium

Generic name (nonproprietary)

montelukast sodium

Active ingredients

Montelukast sodium — 10 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Camber Pharmaceuticals, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 202843

Marketing start

Sep 10, 2014

Listing expires

Dec 31, 2026

Other FDA classes

Leukotriene Receptor Antagonists (Mechanism)

Identifiers

Product ID 31722-726_30387eb8-222d-146e-e063-6294a90a12a7SPL ID 30387eb8-222d-146e-e063-6294a90a12a7SPL set ID 97a682c2-7e00-4d07-a5ac-4436c977f842RxCUI 200224UNII U1O3J18SFLUPC 0331722726306

Pharmacologic class

Leukotriene Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722072601 followed by a unit qualifier and the quantity Copy

Package 31722-0726-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 202843

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.